MichaelDavidCraigMD
Oncology • Morgantown, WVHematologic Oncology
Associate Professor, Medicine, West Virginia University School of Medicine
Are you Dr. Craig?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 40 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Medical Center Drive
Morgantown, WV 26506Phone+1 304-598-4000Fax+1 304-598-6831- Is this information wrong?
Summary
- Dr. Michael Craig, MD is an oncologist in Morgantown, West Virginia. He is currently licensed to practice medicine in West Virginia, Pennsylvania, and California. He is affiliated with West Virginia University Hospitals and is an Associate Professor at West Virginia University School of Medicine.
Education & Training
West Virginia UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005- West Virginia University School of MedicineClass of 2000
Certifications & Licensure
HI State Medical License 2017 - 2026
MD State Medical License 2016 - 2022
PA State Medical License 2020 - 2022
WV State Medical License 2002 - 2022
CA State Medical License 2019 - 2021
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation Start of enrollment: 2010 Oct 12
- Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP) Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.Altman, J., Zuckerman, T., Koprivnikar, J., McCloskey, J., Kota, V., Keng, M., Frankfurt, O., Abaza, Y., Bixby, D., Emadi, A., Burch, M., Bhatnagar, B., Luger, S., Per...> ;Blood Advances. 2023 Dec 26
- 2 citationsChemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia.Debbie Piktel, Javohn C Moore, Sloan Nesbit, Samuel A Sprowls, Michael D Craig, Stephanie L Rellick, Rajesh R Nair, Ethan Meadows, John M Hollander, Werner J Geldenhuy...> ;Cancers. 2023 Jan 24
- 1 citationsAssociation of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia.Carl Shultz, Christopher Gates, William Petros, Kelly Ross, Laruen Veltri, Michael Craig, Sijin Wen, Donald A Primerano, Lori Hazlehurst, James Denvir, Konstantinos Sd...> ;Cancer Reports. 2023 Mar 1
- Join now to see all
Hospital Affiliations
West Virginia University HospitalsMorgantown, West Virginia
